Related Articles
Blood‑based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer‑risk stratification
Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone
The auxiliary diagnostic value of prostate‑specific antigen and α‑methylacyl‑CoA racemase in prostate cancer
Overexpression levels of cripto‑1 predict poor prognosis in patients with prostate cancer following radical prostatectomy
miR-20b-5p is a novel biomarker for detecting prostate cancer